NEWS
PTA Balloon Catheter has been approved by NMPA
Recently, the Falspeed® peripheral vascular balloon dilatation catheter independently developed by Kossel Medtech has been approved by the National Medical Products Administration (NMPA) for marketing!
Kossel Was Successfully Awarded As The “Specialized,Superior, Extraordinary,New” Enterprise In Suzhou High-Tech Zone 2022
Recently, the 2022 Suzhou high-tech zone ” Specialized,Superior, Extraordinary,New ” enterprises list was announced, and Kossel Medtech (Suzhou) Co., Ltd. was successfully selected into it!
Layout three business segments to develop platform enterprises
Kossel MedTech is positioned as a platform enterprise with comprehensive R&D production capacity for vascular intervention. With a full range of balloon catheters, metal stents,
One Clinical Case of Kossel Octoparms® Filter in Guangdong Province
Great Thanks to Professor Geng Wang and Professor Quanhui Wu, they and their teams placed a vena cava filter for a female patient, which helps
Kossel was selected into the list of key enterprises for intellectual property protection
Recently, Kossel Medtech has been successfully selected into the “Second Batch of Key Enterprises for Intellectual Property Rights Protection in Suzhou”. As a platform enterprise
Kossel Brand Image Refresh
Kossel is always focusing on vascular intervention devices’ R&D and production,such as PTCA balloon dilatation catheter, PTA balloon catheter etc. In 2022,we upgrade our brand image